Cite

MLA Citation

    Jeffrey Weber et al.. “Pre-treatment patient selection for nivolumab benefit based on serum mass spectra.” Journal for immunotherapy of cancer, vol. 3, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100137791881.0x000004
  
Back to record